198 related articles for article (PubMed ID: 16369893)
1. Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice.
Iguchi H; Aramaki Y; Maruta S; Takiguchi S
J Bone Miner Metab; 2006; 24(1):16-9. PubMed ID: 16369893
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
Sato K; Onuma E; Yocum RC; Ogata E
Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
[TBL] [Abstract][Full Text] [Related]
3. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.
Capparelli C; Kostenuik PJ; Morony S; Starnes C; Weimann B; Van G; Scully S; Qi M; Lacey DL; Dunstan CR
Cancer Res; 2000 Feb; 60(4):783-7. PubMed ID: 10706080
[TBL] [Abstract][Full Text] [Related]
5. Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.
Fujimoto-Ouchi K; Onuma E; Shirane M; Mori K; Tanaka Y
Cancer Chemother Pharmacol; 2007 May; 59(6):807-15. PubMed ID: 17009035
[TBL] [Abstract][Full Text] [Related]
6. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.
Iguchi H; Onuma E; Sato K; Sato K; Ogata E
Int J Cancer; 2001 Oct; 94(1):24-7. PubMed ID: 11668474
[TBL] [Abstract][Full Text] [Related]
7. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
9. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidity.
Ogata E
Cancer; 2000 Jun; 88(12 Suppl):2909-11. PubMed ID: 10898333
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts.
Onuma E; Tsunenari T; Saito H; Sato K; Yamada-Okabe H; Ogata E
Int J Cancer; 2005 Sep; 116(3):471-8. PubMed ID: 15800941
[TBL] [Abstract][Full Text] [Related]
13. Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats.
Suzuki H; Hashimoto H; Kawasaki M; Watanabe M; Otsubo H; Ishikura T; Fujihara H; Ohnishi H; Onuma E; Yamada-Okabe H; Takuwa Y; Ogata E; Nakamura T; Ueta Y
Int J Cancer; 2011 May; 128(9):2215-23. PubMed ID: 20602340
[TBL] [Abstract][Full Text] [Related]
14. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
15. [PTHrP and cancer cachexia].
Onuma E; Okabe H
Clin Calcium; 2008 Apr; 18(4):489-98. PubMed ID: 18379031
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Morony S; Warmington K; Adamu S; Asuncion F; Geng Z; Grisanti M; Tan HL; Capparelli C; Starnes C; Weimann B; Dunstan CR; Kostenuik PJ
Endocrinology; 2005 Aug; 146(8):3235-43. PubMed ID: 15845617
[TBL] [Abstract][Full Text] [Related]
17. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
Morony S; Capparelli C; Lee R; Shimamoto G; Boone T; Lacey DL; Dunstan CR
J Bone Miner Res; 1999 Sep; 14(9):1478-85. PubMed ID: 10469275
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
19. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy.
Akatsu T; Murakami T; Ono K; Nishikawa M; Tsuda E; Mochizuki SI; Fujise N; Higashio K; Motoyoshi K; Yamamoto M; Nagata N
Bone; 1998 Dec; 23(6):495-8. PubMed ID: 9855457
[TBL] [Abstract][Full Text] [Related]
20. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts.
Boabaid F; Berry JE; Koh AJ; Somerman MJ; McCcauley LK
J Periodontol; 2004 Sep; 75(9):1247-54. PubMed ID: 15515341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
